These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 662227)

  • 1. Hormonal effects of wedge resection of polycystic ovaries.
    Katz M; Carr PJ; Cohen BM; Millar RP
    Obstet Gynecol; 1978 Apr; 51(4):437-44. PubMed ID: 662227
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Levels of follicle-stimulating hormone, luteinizing hormone, oestradiol-17 beta and progesterone, and follicular growth in the pseudopregnant rat.
    Welschen R; Osman P; Dullaart J; de Greef WJ; Uilenbroek JT; de Jong FH
    J Endocrinol; 1975 Jan; 64(1):37-47. PubMed ID: 1167896
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hormone levels following wedge resection in polycystic ovary syndrome.
    Mahesh VB; Toledo SP; Mattar E
    Obstet Gynecol; 1978 Jan; 51(1 Suppl):64s-69s. PubMed ID: 144874
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of ovarian wedge resection on circulating gonadotropin and ovarian steroid levels in patients with polycystic ovary syndrome.
    Judd HL; Rigg LA; Anderson DC; Yen SS
    J Clin Endocrinol Metab; 1976 Aug; 43(2):347-55. PubMed ID: 950366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Temporal relationships between ovulation and defined changes in the concentration of plasma estradiol-17 beta, luteinizing hormone, follicle-stimulating hormone, and progesterone. I. Probit analysis. World Health Organization, Task Force on Methods for the Determination of the Fertile Period, Special Programme of Research, Development and Research Training in Human Reproduction.
    Am J Obstet Gynecol; 1980 Oct; 138(4):383-90. PubMed ID: 6775535
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pituitary-ovarian relationships preceding the menopause. I. A cross-sectional study of serum follice-stimulating hormone, luteinizing hormone, prolactin, estradiol, and progesterone levels.
    Reyes FI; Winter JS; Faiman C
    Am J Obstet Gynecol; 1977 Nov; 129(5):557-64. PubMed ID: 910845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effect of celioscopic ovarian resection in patients with polycystic ovaries.
    Campo S; Garcea N; Caruso A; Siccardi P
    Gynecol Obstet Invest; 1983; 15(4):213-22. PubMed ID: 6220946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Differences in hormonal patterns during the first postabortion menstrual cycle after two techniques of termination of pregnancy.
    Blazar AS; Harlin J; Zaidi AA; Diczfalusy E
    Fertil Steril; 1980 May; 33(5):493-500. PubMed ID: 6768597
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extremely high levels of estradiol and testosterone in a case of polycystic ovarian syndrome. Hormone and clinical similarities with the phenotype of the alpha estrogen receptor null mice.
    Bartolone L; Smedile G; Arcoraci V; Trimarchi F; Benvenga S
    J Endocrinol Invest; 2000; 23(7):467-72. PubMed ID: 11005272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Temporal relations between plasma concentrations of luteinizing hormone, follicle-stimulating hormone, estradiol-17beta, progesterone, prolactin, and alpha-melanocyte-stimulating hormone during the follicular, ovulatory, and early luteal phase in the bitch.
    de Gier J; Kooistra HS; Djajadiningrat-Laanen SC; Dieleman SJ; Okkens AC
    Theriogenology; 2006 Apr; 65(7):1346-59. PubMed ID: 16197989
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of ovarian wedge resection for the Stein-Leventhal syndrome on plasma FSH, LH, oestradiol and testosterone levels and on the responses of the pituitary to intravenous LHRH.
    Valkov IM; Dokumov SI
    Br J Obstet Gynaecol; 1977 Jul; 84(7):539-42. PubMed ID: 334239
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Characterization of the inappropriate gonadotropin secretion in polycystic ovary syndrome.
    Rebar R; Judd HL; Yen SS; Rakoff J; Vandenberg G; Naftolin F
    J Clin Invest; 1976 May; 57(5):1320-9. PubMed ID: 770505
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Recovery of hormone secretion after chronic gonadotropin-releasing hormone agonist administration in women with polycystic ovarian disease.
    de Ziegler D; Steingold K; Cedars M; Lu JK; Meldrum DR; Judd HL; Chang RJ
    J Clin Endocrinol Metab; 1989 Jun; 68(6):1111-7. PubMed ID: 2524501
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Inhibition of ovulation during discontinuous intranasal luteinizing hormone-releasing hormone agonist dosing in combination with gestagen-induced bleeding.
    Lemay A; Faure N; Labrie F; Fazekas AT
    Fertil Steril; 1985 Jun; 43(6):868-77. PubMed ID: 3158551
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Circulating levels of LH, FSH and basal steroids in subjects with polycystic ovary syndrome before and after wedge resection of the ovaries].
    Ragucci N; Amato G; Izzo A
    Arch Ostet Ginecol; 1981; 86(5-6):263-79. PubMed ID: 6819842
    [No Abstract]   [Full Text] [Related]  

  • 16. The effect of ovarian wedge resection and incision on circulating gonadotropin in patients with polycystic ovarian disease.
    Tanaka T; Fujimoto S; Kutsuzawa T
    Int J Fertil; 1978; 23(2):93-9. PubMed ID: 30730
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hormonal and clinical effects of multifollicular puncture and resection on the ovaries of polycystic ovary syndrome.
    Utsunomiya T; Sumioki H; Taniguchi I
    Horm Res; 1990; 33 Suppl 2():35-9. PubMed ID: 2151330
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Measurement of serum LH, FSH, progesterone, 17-hydroxy-progesterone and estradiol-17beta levels at 4-hour intervals during the periovulatory phase of the menstrual cycle.
    Thorneycroft IH; Sribyatta B; Tom WK; Nakamura RM; Mishell DR
    J Clin Endocrinol Metab; 1974 Oct; 39(4):754-8. PubMed ID: 4414601
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduction of gonadotropin-releasing hormone pulse frequency is associated with subsequent selective follicle-stimulating hormone secretion in women with polycystic ovarian disease.
    Christman GM; Randolph JF; Kelch RP; Marshall JC
    J Clin Endocrinol Metab; 1991 Jun; 72(6):1278-85. PubMed ID: 1902845
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ovarian morphology as a predictor of hormonal values in polycystic ovary syndrome.
    van der Westhuizen S; van der Spuy ZM
    Ultrasound Obstet Gynecol; 1996 May; 7(5):335-41. PubMed ID: 8774098
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.